about
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the EvidenceThe Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats.Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake rats.Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigationsInflammatory molecular signature associated with infectious agents in psychosis.Therapeutic Potential of Cannabinoids in Psychosis.IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.What is the promise of nicotinergic compounds in schizophrenia treatment?Motor impairment and compensation in a hemiparkinsonian rat model: correlation between dopamine depletion severity, cerebral metabolism and gait patterns.PT600. Oylethanolamide Modulates Human Neural Responses to Food Stimuli in Obesity.Oleoylethanolamide and human neural responses to food stimuli in obesity.Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder.Association of anandamide with altered binocular depth inversion illusion in schizophrenia.Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders.Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients.Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivityFamilial abnormalities of endocannabinoid signaling in schizophreniaCannabidiol zur Verbesserung der Genesung in frühen Stadien einer Schizophrenie570. Differential Association of Anandamide Levels with Binocular Depth Inversion Illusion Scores in SchizophreniaList of ContributorsPutative Role of Endocannabinoids in SchizophreniaCannabinoids and schizophreniaSleep deprivation in humans: Effects on melatonin in cerebrospinal fluid and serumA TWIN STUDY ON ABNORMALITIES OF ENDOCANNABINOID FUNCTIONING IN SCHIZOPHRENIA AND BIPOLAR DISORDERRole of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological InterventionRight care, first time: a highly personalised and measurement-based care model to manage youth mental healthCannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humansDifferent pharmaceutical preparations of Δ9 -tetrahydrocannabinol differentially affect its behavioral effects in ratsYouth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health services
P50
Q28075499-C4867031-9F2C-493D-A6F6-0BBE0184166EQ30377166-7D36E6EC-D6AD-4627-90E1-2802EDEF4D4BQ30437145-BBD75F18-4206-49E5-B381-60D12AE1F4C9Q33762566-1E2749C3-6A32-4C54-AA5D-F6DA66BB4975Q34048637-C051EB55-AD09-43B0-915D-AB117763D475Q34512679-2549811D-FE33-4B64-B268-3803A6956539Q34764938-5EE56D03-3E47-4465-A7AF-9E3152A5C504Q38811805-0D35C931-988B-4D69-8847-50E52818EDF1Q41492379-EF27CFD5-9725-4905-8764-94A14C483E1BQ47147560-174CDC4B-6BA3-4542-95FB-590676F398F4Q47728389-5FD73FE1-60EF-46FF-BF74-1A2AC7DC1625Q47852602-CDBEA9F8-A524-4590-99A9-1D6C28DA17E2Q47916072-2400E092-76EB-4E56-B4C0-259F957C3CC4Q50675640-475C352B-29E3-442C-8430-4BAE605AFAACQ52647455-0F3DEE12-8ED8-48AF-92E3-DF9ED40ECB43Q60290296-45CA1D5D-580B-4228-9AFC-D17D4B52CC90Q60434482-24D174A1-6795-4499-B7D9-BA16409637BBQ60434486-E4641B36-A676-44C6-A70A-9D13514BB149Q60434489-DF25BDB3-E78A-46A8-BBB2-75E33FEE67F7Q60434490-56DCD7EB-5A8B-4CC4-8227-5289E5418369Q60434492-E9CF0642-ACEA-474E-8886-0CAF295C84B5Q60434498-0AB318DD-4C78-496B-961E-45AE4EE8FE83Q60434513-5E70BE9B-1E7F-43FF-BAAB-25AE5975FCCCQ60434519-65E8BDD2-C860-4EFD-8AC4-88975E58E4FDQ90325053-D601CC5B-49A4-4ADD-B026-5D0E8EDA7DB9Q91073974-3EA33324-4408-4510-8994-CF10CCF7A99EQ91242516-95C5EA3D-36A2-4EB3-922F-7D3B65B233F4Q92781544-6134640F-B5CA-4C06-96E8-BF8B38878CDCQ96230114-EBEAC6F0-EDE3-4711-8ED1-5F956B6D9CAB
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Cathrin Rohleder
@ast
Cathrin Rohleder
@en
Cathrin Rohleder
@es
Cathrin Rohleder
@nl
Cathrin Rohleder
@sl
type
label
Cathrin Rohleder
@ast
Cathrin Rohleder
@en
Cathrin Rohleder
@es
Cathrin Rohleder
@nl
Cathrin Rohleder
@sl
prefLabel
Cathrin Rohleder
@ast
Cathrin Rohleder
@en
Cathrin Rohleder
@es
Cathrin Rohleder
@nl
Cathrin Rohleder
@sl
P214
P106
P108
P1153
55928440200
P21
P214
P31
P496
0000-0002-3559-1846
P734
P735
P7859
viaf-253079259